Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 48Gynecologic 4Gastrointestinal 3Tumor-Agnostic 2Thoracic 2Other solid neoplasm 2Sarcoma 1Head & Neck 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Glioma 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 73Temozolomide 70Specimen Handling 49Radiotherapy 41Radiosurgery 31Radiation 26Cyclophosphamide 26Bevacizumab 26Nivolumab 23Biopsy 21pembrolizumab 20Carboplatin 16X-Rays 15Lomustine 14Ipilimumab 14fludarabine 12Vincristine 12Irinotecan 12Cisplatin 12Topotecan 11Surgical Procedures, Operative 11Blood Specimen Collection 11trametinib 9dinutuximab 9Immunoglobulin G 8Etoposide 8Doxorubicin 8AZD 6244 8lutetium Lu 177 dotatate 7fludarabine phosphate 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
ribociclib × CNS × 90 days × Clear all
NCT05843253 2026-05-29

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡